Gary R. Point
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 4
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 1
- Cytokine Signaling Pathways and Interactions 1
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 1
- Immune cells in cancer 1
- Co-authors
- Mitchell Thorn (4 shared papers)Steven C. Katz (4 shared papers)N. Joseph Espat (4 shared papers)Richard P. Junghans (3 shared papers)Rachel A. Burga (3 shared papers)Prajna Guha (2 shared papers)Earle O. Assanah (1 shared paper)Brian F. Stainken (1 shared paper)
- Journals
- ACS Chemical Biology (1 paper)Cancer Gene Therapy (1 paper)Cancer Immunology Immunotherapy (1 paper)Clinical Cancer Research (1 paper)Journal of Leukocyte Biology (1 paper)
- Partner nations
- United States
In The Last Decade
Gary R. Point
6 papers receiving 795 citations
Peers
Comparison fields: 5 of 56
- Oncology 620
- Immunology 273
- Genetics 170
- Urology 31
- Biomedical Engineering 192
Countries citing papers authored by Gary R. Point
This map shows the geographic impact of Gary R. Point's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Point with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Point more than expected).
Fields of papers citing papers by Gary R. Point
This network shows the impact of papers produced by Gary R. Point. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Point. The network helps show where Gary R. Point may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary R. Point, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 329 | |
| 2 | 2015 | 192 | |
| 3 | 2016 | 146 | |
| 4 | 2019 | 125 | |
| 5 | 2014 | 15 | |
| 6 | 2021 | 3 |
About Gary R. Point
Gary R. Point is a scholar working on Oncology, Immunology, Surgery, Genetics and Infectious Diseases, having authored 6 papers that have together received 810 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (3 papers), Intraperitoneal and Appendiceal Malignancies (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Immunotherapy and Immune Responses (1 paper) and Immune cells in cancer (1 paper). The work is most often cited by research in Oncology (620 citations), Immunology (273 citations), Genetics (170 citations), Urology (31 citations) and Biomedical Engineering (192 citations). Gary R. Point has collaborated with scholars based in United States. Frequent co-authors include Mitchell Thorn, Steven C. Katz, N. Joseph Espat, Richard P. Junghans, Rachel A. Burga, Prajna Guha, Earle O. Assanah, Brian F. Stainken, Pranay D. Khare and Qiangzhong Ma. Their work appears in journals such as ACS Chemical Biology, Cancer Gene Therapy, Cancer Immunology Immunotherapy, Clinical Cancer Research and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.